Lumida
/TECH
⌘K
Bio-Techne Corp

Bio-Techne Corp

TECH
$72.12USD+0.06%+0.04 today

MARKET CAP

11.3B

P/E (TTM)

37.3x

FWD P/E

33.9x

DAY RANGE

$72 – $72

52W RANGE

$43
$73

AI Summary

Stalk
StalkMedium

TECH is stalled near multi-month highs at the historical resistance zone around $72, with converging EMAs tracking underneath. Long- and medium-term biases remain bullish based on a rising long-term trend and Stage 2 advance, but an active bullish exhaustion pattern highlights weakening upside momentum and leaves no clear short-term entry. Execution is best deferred until a decisive breakout above resistance or a pullback into rising EMAs.

  • Q1 2027 revenue of $79.1M and GPU cloud ARR ~$110M show robust demand.
  • Earnings yield ~29% indicates attractive valuation for investors.
  • Negative growth factors signal potential stagnation in revenue expansion.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$931.0M$1.1B$1.1B$1.2B$1.2B
YoY %+26.0%+18.7%+2.8%+2.0%+5.2%
P / Sales19.6x12.9x11.6x9.9x6.7x
EV / Sales20.1x13.2x12.1x10.3x7.1x
Gross Profit, Adj.$632.9M$756.5M$769.8M$769.7M$790.3M
YoY %+31.0%+19.5%+1.8%-0.0%+2.7%
Margin %68.0%68.4%67.7%66.4%64.8%
EV / Gross Profit29.6x19.4x17.8x15.6x11.0x
EBITDA, Adj.$325.0M$397.7M$406.2M$318.4M$212.2M
YoY %+35.3%+22.3%+2.1%-21.6%-33.4%
Margin %34.9%36.0%35.7%27.5%17.4%
EV / EBITDA57.6x36.8x33.7x37.7x41.0x
EBIT$237.3M$296.6M$298.9M$206.7M$102.3M
YoY %+50.7%+25.0%+0.8%-30.9%-50.5%
Margin %25.5%26.8%26.3%17.8%8.4%
EV / EBIT78.9x49.4x45.8x58.0x85.0x
Net Income$140.4M$272.1M$285.3M$168.1M$73.4M
YoY %-38.8%+93.8%+4.9%-41.1%-56.3%
Net Margin15.1%24.6%25.1%14.5%6.0%
EPS (GAAP)$0.87$1.66$1.76$1.05$0.46
YoY %-40.4%+90.8%+6.0%-40.3%-56.2%